Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Michael D. Schultz, John J. Suschak, Davide Botta, Aaron Silva-Sanchez, R. Glenn King, Thomas W. Detchemendy, Chetan D. Meshram, Jeremy B. Foote, Fen Zhou, Jennifer L. Tipper, Jianfeng Zhang, Kevin S. Harrod, Sixto M. Leal$suffix/text()$suffix/text(), Troy D. Randall, M. Scot Roberts, Bertrand Georges & Frances E. Lund. (2022) A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Lasse Neukirch, Cyrielle Fougeroux, Anne-Marie Carola Andersson & Peter Johannes Holst. (2020) The potential of adenoviral vaccine vectors with altered antigen presentation capabilities. Expert Review of Vaccines 19:1, pages 25-41.
Read now
Read now
Siqingaowa Suo & Xiaofeng Ren. (2016) Importance of interferon inducible trans-membrane proteins and retinoic acid inducible gene I for influenza virus replication: A review. Critical Reviews in Microbiology 42:1, pages 75-82.
Read now
Read now
Kui Xiang, Guan Ying, Zhou Yan, Yan Shanshan, Zhang Lei, Li Hongjun & Sun Maosheng. (2015) Progress on adenovirus-vectored universal influenza vaccines. Human Vaccines & Immunotherapeutics 11:5, pages 1209-1222.
Read now
Read now
De-chu C Tang. (2012) Perspectives on replication-incompetent nasal influenza virus vaccines. Expert Review of Vaccines 11:8, pages 907-909.
Read now
Read now
Philip Dormitzer, Theodore Tsai & Giuseppe Del Giudice. (2012) New technologies for influenza vaccines. Human Vaccines & Immunotherapeutics 8:1, pages 45-58.
Read now
Read now
Jianfeng Zhang, E Bart Tarbet, Haroldo Toro & De-chu C Tang. (2011) Adenovirus-vectored drug–vaccine duo as a potential driver for conferring mass protection against infectious diseases. Expert Review of Vaccines 10:11, pages 1539-1552.
Read now
Read now
Articles from other publishers (26)
Ruth Hunegnaw, Andrea S. Vicari & Nancy J. Sullivan. 2023. Plotkin's Vaccines. Plotkin's Vaccines
311
329.e6
.
Maireid B. Bull, Carolyn A. Cohen, Nancy H.L. Leung & Sophie A. Valkenburg. (2021) Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread. Viruses 13:9, pages 1779.
Crossref
Crossref
R. Glenn King, Aaron Silva-Sanchez, Jessica N. Peel, Davide Botta, Alexandria M. Dickson, Amelia K. Pinto, Selene Meza-Perez, S. Rameeza Allie, Michael D. Schultz, Mingyong Liu, John E. Bradley, Shihong Qiu, Guang Yang, Fen Zhou, Esther Zumaquero, Thomas S. Simpler, Betty Mousseau, John T. KillianJr.Jr., Brittany Dean, Qiao Shang, Jennifer L. Tipper, Christopher A. Risley, Kevin S. Harrod, Tsungwei Feng, Young Lee, Bethlehem Shiberu, Vyjayanthi Krishnan, Isabelle Peguillet, Jianfeng Zhang, Todd J. Green, Troy D. Randall, John J. Suschak, Bertrand Georges, James D. Brien, Frances E. Lund & M. Scot Roberts. (2021) Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge. Vaccines 9:8, pages 881.
Crossref
Crossref
María J. Leiva-Carrasco, Silvana Jiménez-Chávez, David J. Harvey, Natalie C. Parra, Kaio C. Tavares, Frank Camacho, Alain González, Oliberto Sánchez, Raquel Montesino & Jorge R. Toledo. (2021) In vivo modification of the goat mammary gland glycosylation pathway. New Biotechnology 61, pages 11-21.
Crossref
Crossref
Gregory A. Tannock, Hyunsuh Kim & Lumin Xue. (2019) Why are vaccines against many human viral diseases still unavailable; an historic perspective?. Journal of Medical Virology 92:2, pages 129-138.
Crossref
Crossref
Piyush K. Sharma, Igor P. Dmitriev, Elena A. Kashentseva, Geert Raes, Lijin Li, Samuel W. Kim, Zhi-Hong Lu, Jeffrey M. Arbeit, Timothy P. Fleming, Sergey A. Kaliberov, S. Peter Goedegebuure, David T. Curiel & William E. Gillanders. (2017) Development of an adenovirus vector vaccine platform for targeting dendritic cells. Cancer Gene Therapy 25:1-2, pages 27-38.
Crossref
Crossref
Héla Kallel & Amine A. Kamen. (2015) Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials. Biotechnology Journal 10:5, pages 741-747.
Crossref
Crossref
Ernest Milián & Amine A. Kamen. (2015) Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines. BioMed Research International 2015, pages 1-11.
Crossref
Crossref
H. Toro, J. F. Zhang, R. A. Gallardo, V. L. van Santen, F. W. van Ginkel, K. S. Joiner & C. Breedlove. (2014) S1 of Distinct IBV Population Expressed from Recombinant Adenovirus Confers Protection Against Challenge. Avian Diseases 58:2, pages 211-215.
Crossref
Crossref
Chengjun Li, Zhigao Bu & Hualan Chen. (2014) Avian influenza vaccines against H5N1 ‘bird flu’. Trends in Biotechnology 32:3, pages 147-156.
Crossref
Crossref
Anton V. Borovjagin, Jorge G. Gomez-Gutierrez, Haval Shirwan & Qiana L. Matthews. 2014. Novel Technologies for Vaccine Development. Novel Technologies for Vaccine Development
203
271
.
Margarita M. Gomez Lorenzo & Matthew J. Fenton. (2013) Immunobiology of Influenza Vaccines. Chest 143:2, pages 502-510.
Crossref
Crossref
Harish Nair, Eva Lau, W Brooks, Ang Seong, Evropi Theodoratou, Lina Zgaga, Tanvir Huda, Suresh S Jadhav, Igor Rudan & Harry Campbell. (2013) An evaluation of the emerging vaccines against influenza in children. BMC Public Health 13:Suppl 3, pages S14.
Crossref
Crossref
Jianfeng Zhang, Edward Jex, Tsungwei Feng, Gloria S. Sivko, Leslie W. Baillie, Stanley Goldman, Kent R. Van Kampen & De-chu C. Tang. (2013) An Adenovirus-Vectored Nasal Vaccine Confers Rapid and Sustained Protection against Anthrax in a Single-Dose Regimen. Clinical and Vaccine Immunology 20:1, pages 1-8.
Crossref
Crossref
Jianfeng Zhang. (2012) Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines. Viruses 4:11, pages 2711-2735.
Crossref
Crossref
Haroldo Toro, Daniela Pennington, Rodrigo A. Gallardo, Vicky L. van Santen, Frederik W. van Ginkel, JianFeng Zhang & Kellye S. Joiner. (2012) Infectious Bronchitis Virus Subpopulations in Vaccinated Chickens After Challenge. Avian Diseases 56:3, pages 501-508.
Crossref
Crossref
Jianfeng Zhang, E. Bart Tarbet, Tsungwei Feng, Zhongkai Shi, Kent R. Van Kampen & De-chu C. Tang. (2011) Adenovirus-Vectored Drug-Vaccine Duo as a Rapid-Response Tool for Conferring Seamless Protection against Influenza. PLoS ONE 6:7, pages e22605.
Crossref
Crossref
Alexander Mesonero, David L. Suarez, Edzard van Santen, De-chu C. Tang & Haroldo Toro. (2011)
Avian Influenza
In Ovo
Vaccination with Replication Defective Recombinant Adenovirus in Chickens: Vaccine Potency, Antibody Persistence, and Maternal Antibody Transfer
. Avian Diseases 55:2, pages 285-292.
Crossref
Crossref
Irina L. Tutykhina, Denis Y. Logunov, Dmitriy N. Shcherbinin, Maxim M. Shmarov, Amir I. Tukhvatulin, Boris S. Naroditsky & Alexander L. Gintsburg. (2010) Development of adenoviral vector-based mucosal vaccine against influenza. Journal of Molecular Medicine 89:4, pages 331-341.
Crossref
Crossref
Haroldo Toro,David L. Suarez,De-chu C. Tang,Frederik W. van Ginkel,Cassandra Breedlove. (2011) Avian Influenza Mucosal Vaccination in Chickens with Replication-Defective Recombinant Adenovirus Vaccine. Avian Diseases 55:1, pages 43-47.
Crossref
Crossref
Danher Wang, Andreas Suhrbier, Adam Penn-Nicholson, Jan Woraratanadharm, Joy Gardner, Min Luo, Thuy T. Le, Itaru Anraku, Michael Sakalian, David Einfeld & John Y. Dong. (2011) A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis. Vaccine 29:15, pages 2803-2809.
Crossref
Crossref
Isaac Sipo, Mathias Knauf, Henry Fechner, Wolfgang Poller, Oliver Planz, Reinhard Kurth & Stephen Norley. (2011) Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV). Vaccine 29:8, pages 1690-1699.
Crossref
Crossref
Linda C. Lambert & Anthony S. Fauci. (2010) Influenza Vaccines for the Future. New England Journal of Medicine 363:21, pages 2036-2044.
Crossref
Crossref
Imre Kovesdi & Susan J. Hedley. (2010) Adenoviral Producer Cells. Viruses 2:8, pages 1681-1703.
Crossref
Crossref
Iain Stephenson, Frederick Hayden, Albert Osterhaus, Wendy Howard, Yuri Pervikov, Laszlo Palkonyay & Marie-Paule Kieny. (2010) Report of the fourth meeting on ‘Influenza vaccines that induce broad spectrum and long-lasting immune responses’, World Health Organization and Wellcome Trust, London, United Kingdom, 9–10 November 2009. Vaccine 28:23, pages 3875-3882.
Crossref
Crossref
Xiao‐Fei Liu, Yun Shi, Jin‐Yu Zhang, Yuan Zhuang, Ke‐Ran Jia, Xu‐Hu Mao, Ying Guo, Tao Liu, Zhen Liu, Chao Wu, Wei‐Jun Zhang, Wei‐Ying Zhou, Gang Guo & Quan‐Ming Zou. (2009) Efficient adenovirus‐mediated gene transfer to gastric tissue by oral administration. The Journal of Gene Medicine 11:12, pages 1087-1094.
Crossref
Crossref